The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Order GHK Cu (50mg) Buy Research Peptides Medica Depot FDA Review Moves Peptides From Gray Market to Mainstream Fitt Insider The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what